bumetanide has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delpire, E | 1 |
| Gullans, SR | 1 |
| Hoffmann, EK | 1 |
1 review available for bumetanide and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Anion transport systems in the plasma membrane of vertebrate cells.
Topics: Animals; Anions; Axons; Biological Transport; Birds; Bumetanide; Calcium; Calmodulin; Carcinoma, Ehr | 1986 |
1 other study available for bumetanide and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Cell volume and K+ transport during differentiation of mouse erythroleukemia cells.
Topics: Animals; Biological Transport; Bumetanide; Carrier Proteins; Cell Differentiation; Dimethyl Sulfoxid | 1994 |